Orladeyo - Crunchbase Company Profile & Funding

Overview

Orladeyo

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Orladeyo

CB Rank

3802282

Orladeyo is an oral treatment that helps reduce the frequency of hereditary angioedema (HAE) attacks over time.

Acquired by

Neopharmed Gentili

Private

1-10

orladeyo.com

Health Care

Medical

Pharmaceutical

Details

Operating Status

Active

Company Type

For Profit

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ORLADEYO (berotralstat)

An oral prescription medication used to prevent hereditary angioedema (HAE) attacks in patients aged 12 and older.

Empower Patient Services

A patient support program providing assistance with insurance, financial support, medication shipment coordination, and ongoing patient communication for ORLADEYO users.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

M&A Details

Orladeyo

was acquired by

Neopharmed Gentili

for

obfuscation

. This deal was done in

Cash

Transaction Name

Orladeyo acquired by Neopharmed Gentili

Acquired by

Neopharmed Gentili

Announced Date

obfuscation

Price

obfuscation

Market Intelligence

People

View Profiles & Contacts

Headcount

1-10

News

Technology

View Tech Report

Monthly Web Visits

1,169

-86.23%

in past month

IT Spend

$1.2M

This year,

Orladeyo

is projected to spend

$1.2M

on IT, according to Aberdeen.

Active Website Tech Count

Orladeyo

is actively using

technologies for its website, according to BuiltWith. These include

Common Crawl

CommonCrawl Top 50m

, and

DNSSEC

Lists Featuring This Company

Pharmaceutical Acquired Companies

2,323 Number of Organizations • $116.1B Total Funding Amount • 2,789 Number of Investors

Pharmaceutical Acquired Companies With Fewer Than 1000 Employees

1,596 Number of Organizations • $80.2B Total Funding Amount • 2,495 Number of Investors

Medical Companies that Exited

8,134 Number of Organizations • $768.3B Total Funding Amount • 14,875 Number of Investors

Medical Acquired Companies With Fewer Than 1000 Employees

3,068 Number of Organizations • $72.8B Total Funding Amount • 4,638 Number of Investors

Sub-Organizations

Frequently Asked Questions